info@projectetris.eu

Project Partners

Neolys Diagnostics

Neolys Diagnostics is a Biotechnology company specialized in precision medicine for radiation oncology, Neolys Diagnostics develops innovative medical tests combining DNA repair biomarkers and radiotherapy treatment parameters to anticipate and reduce treatment-related side effects, optimize therapeutic efficacy, and contribute to healthcare cost reduction through personalized radiotherapy strategies. 

Dr. Pereira, Sandrine is the Scientific Director of Neolys Diagnostics. With over 15 years of experience in radiosensitivity testing and oncology innovation, Sandrine Pereira leads Work Package 8 (WP8) within the TETRIS Project, ensuring scientific coherence between functional biomarkers, genetic data, and clinical application. Her Team members are Mathilde Hà-Lasnon and Laura Desrivot. 

Neolys Diagnostics – WP8 Leadership: Cellular Sensitivity Testing in the TETRIS Prospective Cohort. 
WP8 focuses on the assessment of cellular radiosensitivity and the integration of functional biomarkers with genetic information, including Polygenic Risk Scores (PRS) derived from SNP analysis, enabling multidimensional patient risk profiling. RadioDTect© and RadioProfile© Assays are Functional radiosensitivity testing assays. The RadioDTect© blood test and RadioProfile© skin test are performed on biological samples collected using standardized protocols from patients enrolled in the TETRIS prospective cohort (WP9). 

Neolys Diagnostics is also part of WP4-Integration of functional and genomic data and WP7- Biological input for Digital Twin development. WP9 – Prospective collection and WP10 – Dissemination and Exploitation. 

Visit Website

Follow Us

@projectetris

⏳ Final Call for Abstracts: VPH 2026 in Milan!

This is the last week to submit your abstract for the VPH 2026 Conference, taking place in Milan, 1-4 September 2026.

Experts, researchers, and innovators are invited to contribute to the dedicated track:
🔬 In Silico Oncology

Within the programme, Tiziana Rancati and Paolo Zunino are coordinating the track “In Silico Oncology”, covering topics such as:
• Multiscale and computational cancer modelling
• AI and machine learning for oncology
• Digital twins and patient-specific models
• Imaging and multimodal data integration
• Translational modelling approaches

📅 Submission Deadline: March 2nd
🔗 Submit your abstract here: https://vph-conference.org/abstract-submission/
🔗 Learn more about the conference and programme: https://vph-conference.org/programme/

Don’t miss the opportunity to contribute to one of the leading international conferences on digital twins and in silico medicine.

#VPH2026 #InSilicoOncology #DigitalTwins #CancerResearch #ComputationalMedicine

@polimi

0 0
Open post by projectetris with ID 18112219552633945
⏳ Final Call for Abstracts: VPH 2026 in Milan! This is the last week to submit your abstract for the VPH 2026 Conference, taking place in Milan, 1-4 September 2026. Experts, researchers, and innovators are invited to contribute to the dedicated track: 🔬 In Silico Oncology Within the programme, Tiziana Rancati and Paolo Zunino are coordinating the track “In Silico Oncology”, covering topics such as: • Multiscale and computational cancer modelling • AI and machine learning for oncology • Digital twins and patient-specific models • Imaging and multimodal data integration • Translational modelling approaches 📅 Submission Deadline: March 2nd 🔗 Submit your abstract here: https://vph-conference.org/abstract-submission/ 🔗 Learn more about the conference and programme: https://vph-conference.org/programme/ Don’t miss the opportunity to contribute to one of the leading international conferences on digital twins and in silico medicine. #VPH2026 #InSilicoOncology #DigitalTwins #CancerResearch #ComputationalMedicine @polimi

...

0 0

@TETRIS 2nd Educational Webinar. One Week to Go!

In just one week, we will host the second webinar of the TETRIS Educational Series.

🗓 Thursday, 26 February
⏰ 13:00–14:00 CET
🎓 “Methods for assessing imaging biomarkers in breast cancer radiotherapy within the TETRIS project”

The session will be delivered by Claudio Fiorino and Martina Mori, who will explore methodological approaches for evaluating imaging biomarkers and their role in personalised risk assessment within TETRIS.

The webinar is open to everyone don’t miss the opportunity to join the discussion and learn more about how imaging supports safer and more personalised radiotherapy.

👉 Connection details are available here: urlr.me/QRzacM

We look forward to welcoming you!@unisr @unisanraffaele

2 0
Open post by projectetris with ID 18003139013853754
@TETRIS 2nd Educational Webinar. One Week to Go! In just one week, we will host the second webinar of the TETRIS Educational Series. 🗓 Thursday, 26 February ⏰ 13:00–14:00 CET 🎓 “Methods for assessing imaging biomarkers in breast cancer radiotherapy within the TETRIS project” The session will be delivered by Claudio Fiorino and Martina Mori, who will explore methodological approaches for evaluating imaging biomarkers and their role in personalised risk assessment within TETRIS. The webinar is open to everyone don’t miss the opportunity to join the discussion and learn more about how imaging supports safer and more personalised radiotherapy. 👉 Connection details are available here: urlr.me/QRzacM We look forward to welcoming you!@unisr @unisanraffaele

...

2 0